Gene Editing

Tsingke Biotech provides a full-spectrum solution for CRISPR-based gene editing, from synthetic guide RNAs and repair templates to custom gene synthesis and expression vector construction. With in-house reagent manufacturing, self-developed synthesizers, and stringent QC workflows, we deliver high-accuracy, reproducible, and scalable gene editing components for both research and therapeutic applications. Our platform supports multiple CRISPR systems, including Cas9, Cas12a (Cpf1), and Cas13, as well as specialized nucleic acid tools for base editing and prime editing.

Types of Gene Editing

Advantages of Tsingke Gene Editing

CRISPR-Focused Platform

Optimized for Cas9, Cas12a, and Cas13 systems.

Accurate QC

ssODN and gRNA validated by mass spectrometry and purity analysis; genes and vectors confirmed by Sanger and NGS.

Full Workflow Integration

From oligos to complete, ready-to-use CRISPR delivery constructs.

In-House Manufacturing

Reagents, instruments, and synthesis capacity under complete quality control.

Scalable Production

Research-scale to GMP-compliant manufacturing for therapeutic applications.

Contact Us

Explore the power of the Gene Factory and discover how Tsingke's integrated platform accelerates your R&D and product development.

Tsingke Updates

2025-12-15

Biologics 2024



2025-11-25

Gene Synthesis: A Booster for the Development of Biological Breeding



Subscribe to Our Newsletter

Stay updated with the latest industry news and expert insights.

Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!

Sitemap | Privacy Policy

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.

Reject Accept